Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019

BACKGROUND/AIMS: The efficacies of lopinavir-ritonavir or hydroxychloroquine remain to be determined in patients with coronavirus disease 2019 (COVID-19). To compare the virological and clinical responses to lopinavir-ritonavir and hydroxychloroquine treatment in COVID-19 patients. METHODS: This ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Won, Kim, Eun Jin, Kwon, Hyun Hee, Jung, Chi Young, Kim, Kyung Chan, Choe, Jung-Yoon, Hong, Hyo-Lim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009163/
https://www.ncbi.nlm.nih.gov/pubmed/32536150
http://dx.doi.org/10.3904/kjim.2020.224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009163/
https://www.ncbi.nlm.nih.gov/pubmed/32536150
http://dx.doi.org/10.3904/kjim.2020.224

Ejemplares similares